Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spek

Showing results (31-40 of 1,464) with videos related to

Pageof 147
Sort By:
Acta Crystallographica. Section C, Crystal Structure Communications|September 15, 2000
The allyl complex di-&mgr;-chloro-bisSpek, Canisius, Preut, et al.
Trends in Cardiovascular Medicine|December 1, 1999
Type-I protein-C deficiency caused by disruption of a hepatocyte nuclear factor (HNF)-6/HNF-1 binding site in the human protein-C gene promoterA Spek, P Reitsma
New Biotechnology|May 28, 2008
The ESF's EuroBioFund: sustainable research financing? Start with networking!Esther Thole, Wouter Spek
Der Urologe. Ausg. A|May 17, 2017
[Urethral (indwelling or intermittent) or suprapubic routes for short-term catheterisation in hospitalized adults]A Spek, S Schmidt
Leukemia Research|August 22, 2009
Targeting the mevalonate pathway in multiple myelomaEllen van der Spek
American Journal of Translational Research|November 10, 2017
Protease activated receptor 2 in diabetic nephropathy: a double edged swordMaaike Waasdorp, JanWillem Duitman, Sandrine Florquin, et al.
The European Respiratory Journal|June 13, 2020
Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?C Arnold Spek, JanWillem Duitman
American Journal of Respiratory and Critical Care Medicine|March 17, 2023
PCSK6: The Endogenous PAR-1 Agonist Driving Pulmonary Fibrosis?C Arnold Spek, JanWillem Duitman
Expert Opinion on Therapeutic Targets|January 22, 2011
Blood coagulation factor Xa as an emerging drug targetKeren Borensztajn, C Arnold Spek
ERJ Open Research|February 7, 2019
Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debateC Arnold Spek, JanWillem Duitman
Pageof 147

Showing results (31-40 of 1,464) with videos related to

Sort By:
Pageof 147
Acta Crystallographica. Section C, Crystal Structure Communications|September 15, 2000
The allyl complex di-&mgr;-chloro-bisSpek, Canisius, Preut, et al.
Trends in Cardiovascular Medicine|December 1, 1999
Type-I protein-C deficiency caused by disruption of a hepatocyte nuclear factor (HNF)-6/HNF-1 binding site in the human protein-C gene promoterA Spek, P Reitsma
New Biotechnology|May 28, 2008
The ESF's EuroBioFund: sustainable research financing? Start with networking!Esther Thole, Wouter Spek
Der Urologe. Ausg. A|May 17, 2017
[Urethral (indwelling or intermittent) or suprapubic routes for short-term catheterisation in hospitalized adults]A Spek, S Schmidt
Leukemia Research|August 22, 2009
Targeting the mevalonate pathway in multiple myelomaEllen van der Spek
American Journal of Translational Research|November 10, 2017
Protease activated receptor 2 in diabetic nephropathy: a double edged swordMaaike Waasdorp, JanWillem Duitman, Sandrine Florquin, et al.
The European Respiratory Journal|June 13, 2020
Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?C Arnold Spek, JanWillem Duitman
American Journal of Respiratory and Critical Care Medicine|March 17, 2023
PCSK6: The Endogenous PAR-1 Agonist Driving Pulmonary Fibrosis?C Arnold Spek, JanWillem Duitman
Expert Opinion on Therapeutic Targets|January 22, 2011
Blood coagulation factor Xa as an emerging drug targetKeren Borensztajn, C Arnold Spek
ERJ Open Research|February 7, 2019
Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debateC Arnold Spek, JanWillem Duitman
Pageof 147